CSF YKL-40 levels are elevated in Alzheimer’s disease and may have value for discriminating subjects with normal cognitive function and patients with Alzheimer’s disease or mild cognitive impairment. Here, CHI3L1 is linked to early-onset autosomal dominant Alzheimer disease.